Juvederm Vollure XC LogoJUVÉDERM VOLLURE™ XC injectable gel is for injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21.

Because JUVÉDERM VOLLURE™ XC delivers subtle, soft volume, it is for the nasolabial folds, which are the most requested dermal filler treatment area. About half of all dermal filler patients receive treatment in this part of the face.

Patients want a product that is long-lasting. So it’s particularly exciting that JUVÉDERM VOLLURE™ XC is the first and only hyaluronic acid (HA) dermal filler FDA-approved to last up to 18 months in moderate to severe wrinkles and folds such as the nasolabial folds. 

As the number of patients seeking dermal filler treatments continues to grow, 5 JUVÉDERM® technology has followed that same trend, with a complete portfolio of products that allow for tailoring of treatment based on specific treatment areas, such as lips, cheeks and lines and wrinkles around the mouth.

The JUVÉDERM® Collection of fillers is the number one selling collection of dermal filler products in the world.

Are you ready to improve your appearance?

Request a consultation

Juvederm Vollure Product Box

The most commonly reported side effects with JUVÉDERM VOLLURE™ XC injectable gel included injection-site redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. Most side effects were mild or moderate and lasted 14 days or less.

One of the risks with using this product is unintentional injection into a blood vessel, and, while rare, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring.

As with all skin injection procedures, there is a risk of infection.

What precautions should my doctor advise me about? 

Tell your doctor if you have a history of excessive scarring (eg, hypertrophic scarring and keloid formations) or pigmentation disorders, as use of this product may result in additional scars or changes in pigmentation. 

Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment.

Patients who experience skin injury near the site of injection with this product may be at a higher risk for side effects.

Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune response, as use of this product may result in an increased risk of infection.

Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site.

Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment.

For more information on JUVÉDERM VOLLURE™ XC, contact our office online.